Literature DB >> 14018308

In vitro studies of mammalian somatic cell variation. I. Detection of H-2 phenotype in cultured mouse cell lines.

H M CANN, L A HERZENBERG.   

Abstract

The isoantigenic phenotype of the H-2 locus has been detected by isohemagglutinin absorption in a line of mouse lymphoma cells growing continuously in culture for 6 years and in two established lines of fibroblastic mouse cells growing continuously in culture for 1 year. Quantitative absorption studies suggest that the concentration of H-2 isoantigens is higher in the cultured lymphoma cells than in the other two fibroblastic cell lines.

Entities:  

Keywords:  BLOOD GROUPS; GENETICS; LYMPHOMA; NEOPLASMS, EXPERIMENTAL; TISSUE CULTURE

Mesh：

Substances：

Year:  1963        PMID： 14018308      PMCID： PMC2137608          DOI： 10.1084/jem.117.2.259

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  10 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  Nutritional requirements for growth of a mouse lymphoma in cell culture.

Authors:  L A HERZENBERG; R A ROOSA
Journal:  Exp Cell Res       Date:  1960-11       Impact factor: 3.905

3.  Association of H-2 antigens with the cell membrane fraction of mouse liver.

Authors:  L A HERZENBERG; L A HERZENBERG
Journal:  Proc Natl Acad Sci U S A       Date:  1961-06-15       Impact factor: 11.205

4.  The mixed antiglobulin reaction in the detection of human isoantibodies against leucocytes, platelets and HeLa cells.

Authors:  D G CHALMERS; R R COOMBS; B W GURNER; J DAUSSET
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

5.  Studies on the mechanism of isoantigenic variant formation in heterozygous mouse tumors. I. Behavior of H-2 antigens D and K: quantitative absorption tests on mouse sarcomas.

Authors:  E KLEIN
Journal:  J Natl Cancer Inst       Date:  1961-11       Impact factor: 13.506

6.  Blood group antigens on HeLa cells shown by mixed agglutination.

Authors:  A KELUS; B W GURNER; R R COOMBS
Journal:  Immunology       Date:  1959-07       Impact factor: 7.397

7.  Serological differences between comparable diploid and tetraploid lines of three mouse ascites tumors.

Authors:  D B AMOS
Journal:  Ann N Y Acad Sci       Date:  1956-03-14       Impact factor: 5.691

8.  A cltrate-phosphatedextrose solution for the preservation of human blood.

Authors:  J G GIBSON; S B REES; T J McMANUS; W A SCHEITLIN
Journal:  Am J Clin Pathol       Date:  1957-12       Impact factor: 2.493

9.  The distribution in the tissues and the development of H-2 antigens of the mouse.

Authors:  O PIZARRO; G HOECKER; P RUBINSTEIN; A RAMOS
Journal:  Proc Natl Acad Sci U S A       Date:  1961-12-15       Impact factor: 11.205

10.  In vitro studies of mammalian somatic cell variation. II. Isoimmune cytotoxicity with a cultured mouse lymphoma and selection of resistant variants.

Authors:  H M CANN; L A HERZENBERG
Journal:  J Exp Med       Date:  1963-02-01       Impact factor: 14.307
  10 in total
  4 in total

1.  Our NIH years: a confluence of beginnings.

Authors:  Leonore A Herzenberg; Leonard A Herzenberg
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

2.  The influence of arboviral infection on the susceptibility of cultured cells to immune injury in vitro.

Authors:  P J Catanzaro; W E Brandt; P K Russell
Journal:  Am J Pathol       Date:  1975-07       Impact factor: 4.307

3.  H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

Authors:  O J Finn; M Lieberman; H S Kaplan
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

4.  In vitro studies of mammalian somatic cell variation. II. Isoimmune cytotoxicity with a cultured mouse lymphoma and selection of resistant variants.

Authors:  H M CANN; L A HERZENBERG
Journal:  J Exp Med       Date:  1963-02-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.